What Researchers Did
Researchers analyzed the clinical and MRI characteristics of levamisole-induced leukoencephalopathy (LILE) in 16 patients with recurrent aphthous ulcers or Ascaris infection.
What They Found
They found that common clinical manifestations included motor weakness (75%), dysphasia or aphasia (50%), and cognitive disorder (50%). MRI scans of all 16 patients revealed demyelinating white matter lesions, with T2-weighted and FLAIR images being highly sensitive, and patients generally recovered with steroid and hyperbaric oxygen therapy.
What This Means for Canadian Patients
Canadian clinicians should consider levamisole-induced leukoencephalopathy (LILE) in patients presenting with neurological symptoms and a history of levamisole exposure, such as through illicit drug use. Recognizing the characteristic clinical and MRI findings can facilitate timely diagnosis and treatment with steroids, potentially leading to patient recovery.
Canadian Relevance
This study was conducted outside of Canada and does not have a direct Canadian connection.
Study Limitations
A key limitation is the small sample size of only 16 patients, which may limit the generalizability of the findings.